Tivic Health® Systems, Inc. (Nasdaq:TIVC), a diversified therapeutics company, announces it has acquired the strategic manufacturing and development assets of Scorpius Holdings, Inc. and is launching Velocity Bioworks™, a wholly owned subsidiary of Tivic, to provide contract development and manufacturing services to Tivic and other companies. “Tivic has entered a new era. With the licensing earlier this year of a Phase III biologic asset and our strategic expansion into biologics, the next logical step is bringing development and manufacturing capabilities in-house,” stated Jennifer Ernst, Tivic CEO.
Read the full article: Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod //
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/tivic-acquires-ready-to-scale-cgmp-manufacturing-and-development-asse-1116694